Interleukin-2 expression and glioma cell proliferation following Vaccinia vector gene transfection in vivo | |
其他题名 | Interleukin-2 expression and glioma cell proliferation following Vaccinia vector gene transfection in vivo |
Wang Xiaogang; Wei Xuezhong; Liu Jiangqiu | |
2008 | |
发表期刊 | NEURAL REGENERATION RESEARCH
![]() |
ISSN | 1673-5374 |
卷号 | 3期号:4页码:415-417 |
摘要 | BACKGROUND: The effectiveness of gene therapy is closely related to the efficiency of vector transfection and expression. |
其他摘要 | BACKGROUND: The effectiveness of gene therapy is closely related to the efficiency of vector transfection and expression.OBJECTIVE: This study was designed to transfect a human brain glioma cell line with recombinant Vaccinia virus expressing the interleukin-2 (rVV-IL-2) gene, and to observe IL-2 expression and glioma cell proliferation potential after transfection.DESIGN: Experimental observation.SETTING: Department of Neurosurgery, Shenyang Military Area Command of Chinese PLA.MATERIALS: The rVV-IL-2 vectors were obtained through homologous recombination and screening in the Second Military Medical University of Chinese PLA. The human brain glioma cell line and IL-2-dependent cells were produced by the Second Military Medical University of Chinese PLA. Human IL-2 was produced by Genzyme Corporation.METHODS: At passage day 1, Vero cells were amplified 1∶1 for virus and cells. A human brain glioma cell line was transfected using amplified Vaccinia viral vectors at varying multiplicities of infection (MOI). At 2, 4, 6, 8, 12, and 24 hours post-transfection, supernatant was collected to determine by MTT assay IL-2 expression levels in IL-2 dependent cells. The transfected and non-transfected cells were divided into 4 groups, namely MOI 1∶1, MOI 5∶1, MOI 10∶1, and control groups.MAIN OUTCOME MEASURES: IL-2 expression at different time points after transfection of human brain glioma cells with varying MOI of Vaccinia viral vectors; in vitro proliferation capacity of human brain glioma cells among the 4 groups.RESULTS: IL-2 expression was detectable 4 hours after Vaccinia viral vector transfection and reached 300 kU/L by 8 hours. There was no significant difference in the proliferating rate of human brain glioma cells among the 4 groups (P > 0.05).CONCLUSION: Vaccinia viral vectors can transfect human brain glioma cells in vitro and express high levels of IL-2.Vaccinia virus and high IL-2 expression do not influence the proliferation rate of human brain glioma cells in vitro. |
关键词 | MURINE MODEL IL-2 THERAPY RESPONSES ANTIGEN CANCER IMMUNITY HEAD Vaccinia virus vector glioma cell proliferation potential in vitro interleukin-2 |
收录类别 | CSCD |
语种 | 英语 |
CSCD记录号 | CSCD:3299687 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.imr.ac.cn/handle/321006/157715 |
专题 | 中国科学院金属研究所 |
作者单位 | 中国科学院金属研究所 |
推荐引用方式 GB/T 7714 | Wang Xiaogang,Wei Xuezhong,Liu Jiangqiu. Interleukin-2 expression and glioma cell proliferation following Vaccinia vector gene transfection in vivo[J]. NEURAL REGENERATION RESEARCH,2008,3(4):415-417. |
APA | Wang Xiaogang,Wei Xuezhong,&Liu Jiangqiu.(2008).Interleukin-2 expression and glioma cell proliferation following Vaccinia vector gene transfection in vivo.NEURAL REGENERATION RESEARCH,3(4),415-417. |
MLA | Wang Xiaogang,et al."Interleukin-2 expression and glioma cell proliferation following Vaccinia vector gene transfection in vivo".NEURAL REGENERATION RESEARCH 3.4(2008):415-417. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论